|
|
|
Biosig Technologies 
|
4.28 -0.12 (-0.03%) |
01-28 10:41 |
Open: |
4.46 |
Pre close: |
4.4 |
Target:
|
6.11
|
High: |
4.58 |
Low: |
4.28 |
Resistance:
|
5.23
6.14
|
Volume: |
129,538 |
Market Cap: |
131M |
Support:
|
3.75
3.12
|
|
|
|
Technical Analysis |
Moving Averages |
MA(5):
|
4.56
 |
MACD |
MACD(12,26):
|
0.02  |
MA(20): |
4.59  |
Signal(12,26,9): |
0.07  |
MA(100): |
4.85  |
Stochastic Oscillator |
%K(14,3):
|
16.23  |
MA(250): |
6.19  |
%D(3): |
26.01  |
Average Volume(K) |
3-Month: |
35620
|
52-Week |
High:
|
12.43 |
10-Days: |
30981 |
Low: |
2.36 |
RSI |
RSI(14):
|
45.24  |
Change(%): |
-10.4 |
Financials, Statistics and Valuation |
EPS |
-2.201 |
Return on Equity (ttm) |
-297.6 |
Shares Out. (M) |
30.72 |
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-161.4 |
Shares Float (M) |
23.27 |
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
22.01 |
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
18.47 |
Forward EPS |
-1.650 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
2480 |
Book Value (p.s.) |
0.950 |
EBITDA (p.s.) |
-2.064 |
P/E |
-1.99 |
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.60 |
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-24.40 |
P/S |
0.00 |
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.02 |
P/CF |
-5.51 |
|
|
|
|
|